Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02770664

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02770664
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02770664. Randomized; double masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2018-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
Condition
ST-segment Elevation Myocardial Infarction
Intervention (Drug)
Placebo
Intervention (Drug)
LC28-0126 Dose A
Intervention (Drug)
LC28-0126 Dose B
Intervention (Drug)
LC28-0126 Dose C
Lead sponsor
LG Life Sciences (class: industry)

Record details

Record id
cardio:ct-nct02770664
Content hash
6c06622b8498ce4e2e7f0372daf97b2e0657c6ae8f0fa9e849250765b0848ef3